A recent study by Cao et al. reported a decreased peripheral CD4+/CD8+ in elderly patients with chronic HF, and immunomodulatory agents administration significantly altered the T-cell subsets and restored the CD4+/CD8+ ratio, improving cardiac function and quality of life [46]. This evidence concerns the gene CD8A and hydrops fetalis.